{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:49:44Z","timestamp":1793936984487,"version":"4.8.0"},"reference-count":148,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a common liver disease worldwide, affected by both genetics and environment. Type 2 diabetes (T2D) stands as an independent environmental risk factor that precipitates the onset of hepatic steatosis and accelerates its progression to severe stages of liver damage. Furthermore, the coexistence of T2D and NAFLD magnifies the risk of cardiovascular disease synergistically. However, the association between genetic susceptibility and metabolic risk factors in NAFLD remains incompletely understood. The glucokinase regulator gene (<jats:italic>GCKR<\/jats:italic>), responsible for encoding the glucokinase regulatory protein (GKRP), acts as a regulator and protector of the glucose-metabolizing enzyme glucokinase (GK) in the liver. Two common variants (rs1260326 and rs780094) within the <jats:italic>GCKR<\/jats:italic> gene have been associated with a lower risk for T2D but a higher risk for NAFLD. Recent studies underscore that T2D presence significantly amplifies the effect of the <jats:italic>GCKR<\/jats:italic> gene, thereby increasing the risk of NASH and fibrosis in NAFLD patients. In this review, we focus on the critical roles of GKRP in T2D and NAFLD, drawing upon insights from genetic and biological studies. Notably, prior attempts at drug development targeting GK with glucokinase activators (GKAs) have shown potential risks of augmented plasma triglycerides or NAFLD. Conversely, overexpression of GKRP in diabetic rats improved glucose tolerance without causing NAFLD, suggesting the crucial regulatory role of GKRP in maintaining hepatic glucose and lipid metabolism balance. Collectively, this review sheds new light on the complex interaction between genes and environment in NAFLD, focusing on the <jats:italic>GCKR<\/jats:italic> gene. By integrating evidence from genetics, biology, and drug development, we reassess the therapeutic potential of targeting GK or GKRP for metabolic disease treatment. Emerging evidence suggests that selectively activating GK or enhancing GK-GKRP binding may represent a holistic strategy for restoring glucose and lipid metabolic balance.<\/jats:p>","DOI":"10.3389\/fendo.2023.1247611","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:55:39Z","timestamp":1693389339000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD"],"prefix":"10.3389","volume":"14","author":[{"given":"Ziqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of nafld and nash: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol (Baltimore Md)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of nash","volume":"77","author":"Tan","year":"2022","journal-title":"Hepatol (Baltimore Md)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(22)00165-0","article-title":"The prevalence and incidence of nafld worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of nafld and nash in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1876","article-title":"Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes","volume":"39","author":"LoMonaco","year":"2016","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25739","article-title":"Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism","volume":"56","author":"Musso","year":"2012","journal-title":"Hepatol (Baltimore Md)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1853","article-title":"Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of nafld, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease among People with Diabetes Versus People without Diabetes: A Multicenter Study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30083","article-title":"Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: A prospective study of 0.5 million people","volume":"68","author":"Pang","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13115","article-title":"Diabetes mellitus in patients with cirrhosis: Clinical implications and management","volume":"36","author":"Elkrief","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/atv.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the american heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arteriosclerosis thrombosis Vasc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"Nafld: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.05.002","article-title":"Genetic insights for drug development in nafld","volume":"40","author":"Eslam","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.257","article-title":"Genetic variation in pnpla3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a tm6sf2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The mboat7-tmc4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712191","article-title":"A protein-truncating hsd17b13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"New Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (Gckr) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2012","journal-title":"Hepatol (Baltimore Md)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on nafld genetics: From new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of nafld and nash: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/hep4.1353","article-title":"Insulin resistance exacerbates genetic predisposition to nonalcoholic fatty liver disease in individuals without diabetes","volume":"3","author":"Barata","year":"2019","journal-title":"Hepatol Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","article-title":"En masse organoid phenotyping informs metabolic-associated genetic susceptibility to nash","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/bf00400825","article-title":"Short-term regulation of glucokinase","author":"Van Schaftingen","year":"1994","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20080595","article-title":"Glucokinase and molecular aspects of liver glycogen metabolism","volume":"414","author":"Agius","year":"2008","journal-title":"Biochem J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0865-z","article-title":"The gckr rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and ogtt-related insulinaemia, and reduced risk of type 2 diabetes","volume":"51","author":"Spars\u00f8","year":"2008","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"K\u00f6ttgen","year":"2010","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-012-1151-9","article-title":"Association between gout and polymorphisms in gckr in male han chinese","volume":"131","author":"Wang","year":"2012","journal-title":"Hum Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004959","article-title":"Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease","volume":"5","author":"Martin","year":"2021","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2016.04.007","article-title":"Four susceptibility loci for gallstone disease identified in a meta-analysis of genome-wide association studies","volume":"151","author":"Joshi","year":"2016","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-79","article-title":"Gckr gene functional variants in type 2 diabetes and metabolic syndrome: Do the rare variants associate with increased carotid intima-media thickness","volume":"9","author":"Moh\u00e1s","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/jpm12020268","article-title":"A multi-gene panel to identify lipedema-predisposing genetic variants by a next-generation sequencing strategy","volume":"12","author":"Michelini","year":"2022","journal-title":"J personalized Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0516","article-title":"Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations","volume":"57","author":"Orho-Melander","year":"2008","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446l variant in gckr associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"316","author":"Saxena","year":"2007","journal-title":"Sci (New York NY)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.cgh.2013.02.011","article-title":"Association between Variants in or near Pnpla3, Gckr, and Ppp1r3b with Ultrasound-Defined Steatosis Based on Data from the Third National Health and Nutrition Examination Survey","volume":"11","author":"Hernaez","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26440","article-title":"Characterization of european ancestry nonalcoholic fatty liver disease-associated variants in individuals of african and hispanic descent","volume":"58","author":"Palmer","year":"2013","journal-title":"Hepatol (Baltimore Md)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.079749","article-title":"Genetic variants in gckr and pnpla3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals","volume":"99","author":"Lin","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185490","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers","volume":"13","author":"Kawaguchi","year":"2018","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0850-x","article-title":"Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: An interaction study with adiponutrin gene","volume":"49","author":"Tan","year":"2014","journal-title":"J Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14006","article-title":"Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease","volume":"39","author":"Hudert","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort (\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15438","article-title":"Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20\u2009Years of follow-up","volume":"42","author":"Holmer","year":"2022","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/apt.16392","article-title":"The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography","volume":"54","author":"Ajmera","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.cgh.2019.01.027","article-title":"Prevalence and risk factors of significant fibrosis in patients with nonalcoholic fatty liver without steatohepatitis","volume":"17","author":"Pelusi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-00941-z","article-title":"Leptin Resistance before and after Obesity: Evidence That Tissue Glucose Uptake Underlies Adipocyte Enlargement and Liver Steatosis\/Steatohepatitis in Zucker Rats from Early-Life Stages","volume":"46","author":"Guzzardi","year":"2022","journal-title":"Int J Obes (2005)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0153","article-title":"A common gene variant in glucokinase regulatory protein interacts with glucose metabolism on diabetic dyslipidemia: The combined codam and hoorn studies","volume":"39","author":"Simons","year":"2016","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-009-0700-3","article-title":"Glucokinase regulatory protein gene polymorphism affects postprandial lipemic response in a dietary intervention study","volume":"126","author":"Shen","year":"2009","journal-title":"Hum Genet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1150","article-title":"Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of european descent: A meta-analysis of 14 cohort studies","volume":"33","author":"Nettleton","year":"2010","journal-title":"Diabetes Care"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020555","article-title":"Glucokinase regulatory protein genetic variant interacts with omega-3 pufa to influence insulin resistance and inflammation in metabolic syndrome","volume":"6","author":"Perez-Martinez","year":"2011","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M057570","article-title":"The N-3 long-chain pufas modulate the impact of the gckr pro446leu polymorphism on triglycerides in adolescents","volume":"56","author":"Rousseaux","year":"2015","journal-title":"J Lipid Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1244-z","article-title":"Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance","volume":"46","author":"Ferre","year":"2003","journal-title":"Diabetologia"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109224","article-title":"Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced nafld","volume":"114","author":"Inci","year":"2023","journal-title":"J Nutr Biochem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2078612","article-title":"Interaction effect between nafld severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis","volume":"14","author":"Kang","year":"2022","journal-title":"Gut Microbes"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1991.tb16218.x","article-title":"Effectors of the regulatory protein acting on liver glucokinase: A kinetic investigation","volume":"200","author":"Detheux","year":"1991","journal-title":"Eur J Biochem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1991.tb16217.x","article-title":"Competitive inhibition of liver glucokinase by its regulatory protein","volume":"200","author":"Vandercammen","year":"1991","journal-title":"Eur J Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1989.tb14538.x","article-title":"A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate","volume":"179","author":"Van Schaftingen","year":"1989","journal-title":"Eur J Biochem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0014-5793(94)80437-0","article-title":"Cloning and sequencing of rat liver cdnas encoding the regulatory protein of glucokinase","volume":"339","author":"Detheux","year":"1994","journal-title":"FEBS Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1505-z","article-title":"Hepatic glucose sensing and integrative pathways in the liver","volume":"71","author":"Oosterveer","year":"2014","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mamMalian hexokinase: Structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J Exp Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.48.30479","article-title":"Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis","volume":"271","author":"Agius","year":"1996","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1023\/a:1027306122336","article-title":"A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering srebp-1c expression","volume":"254","author":"Scott","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312475200","article-title":"Hepatic glucokinase is required for the synergistic action of chrebp and srebp-1c on glycolytic and lipogenic gene expression","volume":"279","author":"Dentin","year":"2004","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.25.14511","article-title":"Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestration mechanism in metabolic regulation","volume":"96","author":"Farrelly","year":"1999","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.11.7826","article-title":"Characterization of glucokinase regulatory protein-deficient mice","volume":"275","author":"Grimsby","year":"2000","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101722","article-title":"The gckr-P446l gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446l mouse-a model for gckr rs1260326","volume":"72","author":"Ford","year":"2023","journal-title":"Mol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.2.179","article-title":"Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus","volume":"46","author":"Brown","year":"1997","journal-title":"Diabetes"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(99)01580-x","article-title":"Evidence for glucose and sorbitol-induced nuclear export of glucokinase regulatory protein in hepatocytes","volume":"462","author":"Mukhtar","year":"1999","journal-title":"FEBS Lett"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.52.37125","article-title":"Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase","volume":"274","author":"Shiota","year":"1999","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(99)00971-0","article-title":"Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase","volume":"456","author":"de la Iglesia","year":"1999","journal-title":"FEBS Lett"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16047377","article-title":"Role of glucokinase in the subcellular localization of glucokinase regulatory protein","volume":"16","author":"Jin","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2004.02.005","article-title":"Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase","volume":"12","author":"Kamata","year":"2004","journal-title":"Structure (London Engl 1993)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.3.535","article-title":"Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators","volume":"53","author":"Brocklehurst","year":"2004","journal-title":"Diabetes"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb19147.x","article-title":"The mechanism by which rat liver glucokinase is inhibited by the regulatory protein","volume":"191","author":"Vandercammen","year":"1990","journal-title":"Eur J Biochem"},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1042\/bj3460413","article-title":"Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: Evidence for two glucose binding sites","author":"Agius","year":"2000","journal-title":"Biochem J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/01.mco.0000078990.96795.cd","article-title":"Effects of fructose on hepatic glucose metabolism","volume":"6","author":"McGuinness","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1301\/002966402320289377","article-title":"Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation","volume":"60","author":"Watford","year":"2002","journal-title":"Nutr Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.3.606","article-title":"Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes","volume":"51","author":"Hawkins","year":"2002","journal-title":"Diabetes"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1042\/bj2960785","article-title":"Intracellular binding of glucokinase in hepatocytes and translocation by glucose, fructose and insulin","volume":"296","author":"Agius","year":"1993","journal-title":"Biochem J"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/jci117880","article-title":"Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (Gtp) in the human liver. Regulation of gene expression in cultured hepatocytes","volume":"95","author":"Iynedjian","year":"1995","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.14.10597","article-title":"The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte","volume":"275","author":"de la Iglesia","year":"2000","journal-title":"J Biol Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/jci46425","article-title":"Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes","volume":"122","author":"Rees","year":"2012","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1290-2","article-title":"Association of gckr rs780094, alone or in combination with gck rs1799884, with type 2 diabetes and related traits in a han chinese population","volume":"52","author":"Qi","year":"2009","journal-title":"Diabetologia"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1807","article-title":"The common P446l polymorphism in gckr inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the desir prospective general french population","volume":"57","author":"Vaxillaire","year":"2008","journal-title":"Diabetes"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/ng.520","article-title":"New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk","volume":"42","author":"Dupuis","year":"2010","journal-title":"Nat Genet"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011690","article-title":"Association of rs780094 in gckr with metabolic traits and incident diabetes and cardiovascular disease: The aric study","volume":"5","author":"Bi","year":"2010","journal-title":"PLoS One"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nat Genet"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12971","article-title":"Gckr and ppp1r3b identified as genome-wide significant loci for plasma lactate: The atherosclerosis risk in communities (Aric) study","volume":"33","author":"Tin","year":"2016","journal-title":"Diabetic Med J Br Diabetic Assoc"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1249637","article-title":"Glucokinase-activating gckr polymorphisms increase plasma levels of triglycerides and free fatty acids, but do not elevate cardiovascular risk in the ludwigshafen risk and cardiovascular health study","volume":"42","author":"Kozian","year":"2010","journal-title":"Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones metabolisme"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1363","article-title":"Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 finnish men","volume":"62","author":"Mahendran","year":"2013","journal-title":"Diabetes"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp489","article-title":"Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms","volume":"19","author":"van der Harst","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"olz","year":"2009","journal-title":"PLoS Genet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1378","article-title":"Hyperglycemia and a common variant of gckr are associated with the levels of eight amino acids in 9,369 finnish men","volume":"61","author":"Stanc\u00e1kov\u00e1","year":"2012","journal-title":"Diabetes"},{"key":"B102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.269","article-title":"Loci influencing lipid levels and coronary heart disease risk in 16 european population cohorts","volume":"41","author":"Aulchenko","year":"2009","journal-title":"Nat Genet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr580","article-title":"Genetic associations with lipoprotein subfractions provide information on their biological nature","volume":"21","author":"Petersen","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M048710","article-title":"Identification of four novel genes contributing to familial elevated plasma hdl cholesterol in humans","volume":"55","author":"Singaraja","year":"2014","journal-title":"J Lipid Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"key":"B106","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1038\/ncomms8754","article-title":"Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels","volume":"6","author":"Setoh","year":"2015","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00948","article-title":"Complement C3 associates with incidence of diabetes, but no evidence of a causal relationship","volume":"102","author":"Born\u00e9","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-016-4058-z","article-title":"Association between pnpla3 (Rs738409), lyplal1 (Rs12137855), ppp1r3b (Rs4240624), gckr (Rs780094), and elevated transaminase levels in overweight\/obese mexican adults","volume":"43","author":"Flores","year":"2016","journal-title":"Mol Biol Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1384","article-title":"An exome-chip association analysis in chinese subjects reveals a functional missense variant of gckr that regulates fgf21 levels","volume":"66","author":"Cheung","year":"2017","journal-title":"Diabetes"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14384","article-title":"The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease","volume":"40","author":"Simons","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B111","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1038\/s41467-021-26536-w","article-title":"Elevated circulating follistatin associates with an increased risk of type 2 diabetes","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr375","article-title":"Gwas of butyrylcholinesterase activity identifies four novel loci, independent effects within bche and secondary associations with metabolic risk factors","volume":"20","author":"Benyamin","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.08.021","article-title":"Discovery and fine mapping of serum protein loci through transethnic meta-analysis","volume":"91","author":"Franceschini","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B114","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1160\/th13-02-0087","article-title":"Gene-centric association signals for haemostasis and thrombosis traits identified with the humancvd beadchip","volume":"110","author":"Gaunt","year":"2013","journal-title":"Thromb haemostasis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor vii, factor viii, and von willebrand factor: The charge (Cohorts for heart and aging research in genome epidemiology) consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw401","article-title":"Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor xi levels","volume":"26","author":"Sennblad","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-283739","article-title":"Genome-wide association study identifies novel loci for plasma levels of protein C: the aric study","volume":"116","author":"Tang","year":"2010","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00214.2013","article-title":"The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell atp homeostasis","volume":"305","author":"Petrie","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1017\/s0029665115002451","article-title":"Dietary carbohydrate and control of hepatic gene expression: Mechanistic links from atp and phosphate ester homeostasis to the carbohydrate-response element-binding protein","volume":"75","author":"Agius","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"B120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/mol.0000000000000155","article-title":"Glucokinase regulatory protein: Complexity at the crossroads of triglyceride and glucose metabolism","volume":"26","author":"Raimondo","year":"2015","journal-title":"Curr Opin lipidology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1172\/jci23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Digestive Dis Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1587","article-title":"Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the gckr gene","volume":"100","author":"Santoro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B125","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/biomedicines8120587","article-title":"Dietary-induced low-grade inflammation in the liver","volume":"8","author":"Power Guerra","year":"2020","journal-title":"Biomedicines"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0212-1","article-title":"Genetic variation in the gckr gene is associated with non-alcoholic fatty liver disease in chinese people","volume":"38","author":"Yang","year":"2011","journal-title":"Mol Biol Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155329","article-title":"Genome-wide association and mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly nash","volume":"137","author":"Larsson","year":"2022","journal-title":"Metabolism: Clin Exp"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01278-z","article-title":"Glucokinase activators for type 2 diabetes: Challenges and future developments","volume":"80","author":"Toulis","year":"2020","journal-title":"Drugs"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1021\/jm3008689","article-title":"Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients","volume":"55","author":"Sarabu","year":"2012","journal-title":"J medicinal Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1200","article-title":"Effects of mk-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes","volume":"34","author":"Meininger","year":"2011","journal-title":"Diabetes Care"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12088","article-title":"Dose-ranging study with the glucokinase activator azd1656 in patients with type 2 diabetes mellitus on metformin","volume":"15","author":"Wilding","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12586","article-title":"Amg 151 (Arry-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes","volume":"18","author":"Katz","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02184.x","article-title":"Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: A warning for therapeutic applications in humans","volume":"168","author":"De Ceuninck","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.5414\/cp201747","article-title":"Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator azd1656, after single ascending doses in healthy subjects during euglycemic clamp","volume":"50","author":"Ericsson","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01661.x","article-title":"Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator azd1656 in patients with type 2 diabetes mellitus","volume":"14","author":"Morrow","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"B136","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2337\/db08-1470","article-title":"Targeting hepatic glucokinase in type 2 diabetes: Weighing the benefits and risks","volume":"58","author":"Agius","year":"2009","journal-title":"Diabetes"},{"key":"B137","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrd2850","article-title":"Assessing the potential of glucokinase activators in diabetes therapy","volume":"8","author":"Matschinsky","year":"2009","journal-title":"Nat Rev Drug Discovery"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.10.2022","article-title":"Metabolic impact of glucokinase overexpression in liver: Lowering of blood glucose in fed rats is accompanied by hyperlipidemia","volume":"48","author":"O'Doherty","year":"1999","journal-title":"Diabetes"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2017","article-title":"Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans","volume":"96","author":"Peter","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/nature12724","article-title":"Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors","volume":"504","author":"Lloyd","year":"2013","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1021\/jm4016735","article-title":"Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept","volume":"57","author":"Ashton","year":"2014","journal-title":"J medicinal Chem"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2014.965681","article-title":"Molecular targeting of the gk-gkrp pathway in diabetes","volume":"19","author":"Hale","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau3441","article-title":"Targeting hepatic glucokinase to treat diabetes with ttp399, a hepatoselective glucokinase activator","volume":"11","author":"Vella","year":"2019","journal-title":"Sci Trans Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01802-6","article-title":"Dorzagliatin in drug-na\u00efve patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial","volume":"28","author":"Zhu","year":"2022","journal-title":"Nat Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh1316","article-title":"Chronotherapy with a glucokinase activator profoundly improves metabolism in obese zucker rats","volume":"14","author":"Kroon","year":"2022","journal-title":"Sci Trans Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.3390\/ijms24054315","article-title":"Glucokinase inactivation ameliorates lipid accumulation and exerts favorable effects on lipid metabolism in hepatocytes","volume":"24","author":"Xie","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2022.12.007","article-title":"Glucokinase activity in diabetes: Too much of a good thing","volume":"34","author":"Ashcroft","year":"2023","journal-title":"Trends Endocrinol metabolism: TEM"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1813","article-title":"Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein","volume":"50","author":"Slosberg","year":"2001","journal-title":"Diabetes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1247611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:55:44Z","timestamp":1693389344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1247611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":148,"alternative-id":["10.3389\/fendo.2023.1247611"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1247611","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"article-number":"1247611"}}